Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colleoni

Showing results (71-80 of 264) with videos related to

Pageof 27
Sort By:
Annals of Surgical Oncology|May 24, 2012
Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidatesOreste Gentilini, Edoardo Botteri, Paolo Veronesi, et al.
Critical Reviews in Oncology/Hematology|February 26, 2022
Low-risk triple-negative breast cancers: Clinico-pathological and molecular featuresNicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Journal of Surgical Oncology|January 31, 2007
Sentinel lymph node biopsy is feasible even after total mastectomyMattia Intra, Paolo Veronesi, Oreste D Gentilini, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2010
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyPer Karlsson, Bernard F Cole, Marco Colleoni, et al.
Breast Care (Basel, Switzerland)|August 3, 2018
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II TrialEmilia Montagna, Vincenzo Bagnardi, Giuseppe Cancello, et al.
Breast (Edinburgh, Scotland)|February 2, 2010
Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancerMonica Iorfida, Vincenzo Bagnardi, Alessandra Balduzzi, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2007
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxelRosalba Torrisi, Alessandra Balduzzi, Raffaella Ghisini, et al.
The Breast Journal|September 30, 2008
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapyClaudia D'Alessandro, Silvia Dellapasqua, Laura Orlando, et al.
The Breast Journal|July 26, 2012
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort reportGaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?Giuseppe Cancello, Patrick Maisonneuve, Manuelita Mazza, et al.
Pageof 27

Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
Annals of Surgical Oncology|May 24, 2012
Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidatesOreste Gentilini, Edoardo Botteri, Paolo Veronesi, et al.
Critical Reviews in Oncology/Hematology|February 26, 2022
Low-risk triple-negative breast cancers: Clinico-pathological and molecular featuresNicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Journal of Surgical Oncology|January 31, 2007
Sentinel lymph node biopsy is feasible even after total mastectomyMattia Intra, Paolo Veronesi, Oreste D Gentilini, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2010
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyPer Karlsson, Bernard F Cole, Marco Colleoni, et al.
Breast Care (Basel, Switzerland)|August 3, 2018
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II TrialEmilia Montagna, Vincenzo Bagnardi, Giuseppe Cancello, et al.
Breast (Edinburgh, Scotland)|February 2, 2010
Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancerMonica Iorfida, Vincenzo Bagnardi, Alessandra Balduzzi, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2007
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxelRosalba Torrisi, Alessandra Balduzzi, Raffaella Ghisini, et al.
The Breast Journal|September 30, 2008
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapyClaudia D'Alessandro, Silvia Dellapasqua, Laura Orlando, et al.
The Breast Journal|July 26, 2012
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort reportGaetano Aurilio, Elisabetta Munzone, Edoardo Botteri, et al.
Breast (Edinburgh, Scotland)|October 5, 2013
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?Giuseppe Cancello, Patrick Maisonneuve, Manuelita Mazza, et al.
Pageof 27